Status:
UNKNOWN
Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2
Lead Sponsor:
Cannabis Research Associates
Conditions:
Covid19
Eligibility:
All Genders
12+ years
Brief Summary
The Therma COVID-19 Rapid Antigen Test is an in vitro rapid, lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in human saliva specimens. This...
Eligibility Criteria
Inclusion
- Participant is willing to sign verbal informed consent form
- Age 12 or older and parents or legal guardians must consent for children as required by law.
- Participant is attending COVID-19 testing centre for a nasopharyngeal swab sample
- Participant is willing to provide a self-collected saliva sample
Exclusion
- 1\. Participant has previously tested positive for COVID-19 within the past 90 days
Key Trial Info
Start Date :
May 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04878068
Start Date
May 15 2021
End Date
June 30 2021
Last Update
May 7 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.